The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal – 8 Issues a Year

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online.

journal cover

+Submit a Manuscript.+


Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

What is Neuromodulation?

Breaking News Share

Primer on Opioids Mentions Spinal Cord Stimulation as a Treatment Alternative

Sept. 18, 2017 - An article on "the top five things to know about opioids" mentions spinal cord stimulation as an advanced pain treatment alternative that can provide sustained pain relief. (Mountain Grove News-Journal)

FDA Approves Spinal Cord Stimulator

Sept. 18, 2017 - Medtronic plc has received FDA approval for a rechargeable spinal cord stimulation system that can be controlled by a tablet device. An article about the development discusses neurostimulation as an alternative to addictive opioid drugs. (Star Tribune)

Study: Non-Invasive Stimulation Reduced Pain After Migraines Began

Sept. 18, 2017 - A presentation at the 18th Congress of the International Headache Society on 57 patients who have participated in a randomized, sham-controlled clinical trial for acute migraine suggests that external trigeminal nerve stimulation can reduce pain of the attacks even three or more hours after an attack began. (Medscape)

Non-Invasive Stimulation Augmented Anxiety Disorder Therapy in Study

Sept. 18, 2017 - A placebo-controlled study showed that 20 minutes of transcranial magnetic stimulation prior to a desensitization exercise, using virtual reality, for study subjects who were afraid of heights had an effect that lasted three months. The active stimulation to the frontal lobe was described as accelerating the therapy to help overcome the anxiety. (Deccan Chronicle)


To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs
Last Updated on Monday, December 12, 2016 10:01 AM